Some problems of the recurrent urolithiasis.
PART I.: The diagnostic and Prognostic valuc of the urine composition.
Article published in Urologia Polska 1996/49/2.
authors
-
Elżbieta Panasiuk-Jarzyło
- Z Instytutu Medycyny Wewnętrznej Centralnego Szpitala Klinicznego Wojskowej Akademii Medycznej w Warszawie
kierownik: prof. dr hab. med. Marian Cholewa.
keywords
-
urinary tract nephrolithiasis biochemical procedures.
summary
- 57 patients with recurrent urolithiasis lasting 12,9-10,5 years (29 F and 28 M
- at age 48,3-12,4 years) were studied with respect to some parameters of 24-hour
- urine composition. More than 80% of all patients had significant metabolic abnor-
- malities contributing to their stone formation. Most common were: hypocitracuria
- 52,6%), hyperuricosuria (48,9%), hypercalciuria (35%
- Only hyperuricosuria and urinary saturation ratio with uric acid correlated si-
- gnificantly with urolithiasis activity measured by new calculi per year per patient.
references
- 1. Coe E: Clinical stone disease. W: Nephrolithiasis. Wyd.: Coe R, Brcnner B., Stein J.
- Churchil Livingstone. N.Y., Edinburgh, London, 1980,1.
- 2. Smith L:, Calcium - containing renal stones. Kidney Int., 1978, 13, 383.
- 3. Chaussy C, Fuchs G':. ESWL: Die Evolution einer Revolution. Urologe (A), 1989,
- 28, 126.
- 4. Pak C: Medical management of nephrolithiasis. J.Urol., 1982, 128, 1157.
- 5. Preminger G.: The metabolic evaluation of patients with recurrent nephrolithiasis: a
- revicw of comprehensive and Simplified approaches. J.Urol., 1989, 141, 760.
- 6. Marshall R., Robertson W: Nomograms for the estimation of saturation of urine
- calcium oxalate, calcium phosphate, magnesium ammonium phosphate, uric acid,
- sodium acid urate, urate and cystine. Clin.Chim.Acta., 1976, 72. 253.
- 7. Hesse A., Klocke K., Schaejfer R. i wsp.: Ergebnisse von Stoffwechseluntcrsuchun-
- geu bei 354 Kalzium - Rezidiv - Harnsteinpatienten. Fortschr.Urol. Nephrol., 1986,
- 25, 15.
- 8. Erickson S:. When should the stone patient be evaluated? Limited evaluation of sin-
- gle stone formers. Med. Clin. North. Am., 1984, 68, 464.
- 9. Nikkila M., Korula T., Jokela II: Urinary citrate excretion in patients with urolithia-
- sis and normal subjects. Eur.Urol.,1989, 16, 382.
- 10. Buiz M., Dulce II:. Enhancement of urinary citrate in oxalate stone formers by the
- intake of kalinę salts. W: Urolithiasis, clinical and basic research. Smith L., Robert-
- son W., Finlayson B. Wyd.: N.Y.Plenum Press, 1981, 881.
- 11. Ettinger B:. Does hyperuricosuria play a role in calcium oxalate lithiasis? J.Urol.,
- 1989, 141, 738.
- 12. Holmes E.Jr.: Uric acid nephrolithiasis. W: Nephrolithiasis. Wyd.: Coe F., Brenner
- B? Stein J. Churchil Livingstone. N.Y. Edinburgh, London, 1980, 180.
- 13. Peacock M.: The mechanisms of hypercalciuria are unnecesary for treatment of re-
- current renal calcium stone fonners. Contrib. Nephrol., 1982, 33, 152.
- 14. Marshall R., Cohrcui M., Hodgkinson A.: Relationship between calcium and oxalate
- acid intake in the diet and their excretion in the urine of normal and renal stone -
- forming subjects. Clin.Sci., 1972, 43, 91.
- 15. Robertson W., Peaeock M, Heyhurn P. i wsp.: Risk factors in calcium stone disease
- of urinary tract. Br. J. Urol., 1978, 50, 449.
- 16. Strauss A., Coe F, Deutsch L. i wsp.: Factors that predict relapse of calcium nephro-
- lithiasis during treatment. Am. J. Med., 1982, 72, 17.
- 17. Ryall R., Marshall R.: The value of the 24-hour urine analysis in the assesement of
- stone fonners attending a general hospital outpatient clinic. Br. J. Urol., 1984, 56,
- 116.
- 18. Tiselius H.G., Almgard L., Larson L. i wsp.: A biochemical basis for grouping of
- patients with nephrolithiasis. Eur. Urol., 1978, 4, 241.
- 19. Ilesse A., Mierseh W.D.: Special aspects of stone composition and aetiology of diffe-
- rent types of urinary calculi. Int. Urol. Nephrol., 1989, 21, 257.
|